The median syndecan-1 level in our patient group resembles mean syndecan-1 level in patients with coronary artery disease (29.5±4.6 ng/mL), in whom the level increased dramatically (98±9.8 ng/mL) after coronary artery bypass grafting [31,32]. Here, SDC1 is linked to coronary artery disorder.